Information and Resources for Health Professionals

  • Professional Membership

    Health Professionals and Organisation may join APMA as a member. This membership allows access to an exclusive member area including resources and information for the individual and their patients.

  • National Action Plan for Pain Management

    The National Strategic Action Plan for Pain Management will provide a key step towards a national and holistic policy framework that will support consumers, health practitioners and the wider community to improve the quality of life for people living with pain, their families and carers and minimise its impact.

  • Pain Research

    Scientists at the Centre for Pain Research are searching for new treatment options for pain. The diversity of researchers applying their skills to pain, covering the breadth of research from discovery to the clinic, combined with cutting edge facilities that drive output, is hard to match internationally. The Centre for Pain Research is the only research centre to have successfully discovered a peptide and translated it to the clinic.

  • QScript info in QLD

    Key points about QScript - Queensland

    - QScript is a read-only system – you don't need to manually enter any data into the system.

    - QScript is a clinical tool to assist you in making a decision about prescribing or dispensing a monitored medicine – QScript does not make the decision for you or prevent you from prescribing or dispensing.

    - Checking QScript before prescribing or dispensing a monitored medicine will be mandatory for relevant practitioners from 28 October 2021.

  • APMA's Core Programs & Services

    PDF document covering all of APMA’s core programs & services in 2022

IMG_0431.JPG

PainNet

PainNet is a series of networking opportunities available across 2021 for professionals, researchers and clinicians in the field of pain management. This initiative aims to bring together the Australian ecosystem of research and clinical efforts to together combat pain and improve the translatable drug and treatment outcomes for those impacted by pain.